Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike de Wit

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Proteomics|January 15, 2014
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profilingMeike de Wit, Huub Kant, Sander R Piersma, et al.
Molecular & Cellular Proteomics : MCP|January 22, 2010
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progressionJakob Albrethsen, Jaco C Knol, Sander R Piersma, et al.
The Journal of Pathology|October 20, 2011
BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gainAnke H Sillars-Hardebol, Beatriz Carvalho, Jeroen Am Beliën, et al.
Gut|December 31, 2011
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Marianne Tijssen, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 20, 2012
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Jeroen A M Beliën, et al.
Gut|September 6, 2011
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progressionMeike de Wit, Connie R Jimenez, Beatriz Carvalho, et al.
Annals of Surgical Oncology|June 20, 2012
Lumican and versican are associated with good outcome in stage II and III colon cancerMeike de Wit, Eric J Th Belt, Pien M Delis-van Diemen, et al.
Proteomics. Clinical Applications|February 15, 2021
Lipopolysaccharide-regulated secretion of soluble and vesicle-based proteins from a panel of colorectal cancer cell linesCira R Garcia de Durango, Madalena N Monteiro, Irene V Bijnsdorp, et al.
The Journal of Pathology|March 29, 2024
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening settingWillemijn de Klaver, Meike de Wit, Anne Bolijn, et al.
Endoscopy International Open|May 11, 2019
CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patientsJasper L A Vleugels, Sanne M van Neerven, Monique E van Leerdam, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Proteomics|January 15, 2014
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profilingMeike de Wit, Huub Kant, Sander R Piersma, et al.
Molecular & Cellular Proteomics : MCP|January 22, 2010
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progressionJakob Albrethsen, Jaco C Knol, Sander R Piersma, et al.
The Journal of Pathology|October 20, 2011
BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gainAnke H Sillars-Hardebol, Beatriz Carvalho, Jeroen Am Beliën, et al.
Gut|December 31, 2011
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Marianne Tijssen, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 20, 2012
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progressionAnke H Sillars-Hardebol, Beatriz Carvalho, Jeroen A M Beliën, et al.
Gut|September 6, 2011
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progressionMeike de Wit, Connie R Jimenez, Beatriz Carvalho, et al.
Annals of Surgical Oncology|June 20, 2012
Lumican and versican are associated with good outcome in stage II and III colon cancerMeike de Wit, Eric J Th Belt, Pien M Delis-van Diemen, et al.
Proteomics. Clinical Applications|February 15, 2021
Lipopolysaccharide-regulated secretion of soluble and vesicle-based proteins from a panel of colorectal cancer cell linesCira R Garcia de Durango, Madalena N Monteiro, Irene V Bijnsdorp, et al.
The Journal of Pathology|March 29, 2024
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening settingWillemijn de Klaver, Meike de Wit, Anne Bolijn, et al.
Endoscopy International Open|May 11, 2019
CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patientsJasper L A Vleugels, Sanne M van Neerven, Monique E van Leerdam, et al.
Pageof 4